Trust-Based Stock Acquisition Rights Incentive Linked to Performance and Contributions
First written in FY2017-Q2. 3 of 9 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2026.
The whole theme swung hardest in 2023: 1 of 10 companies on the "Worse" side.
0 other companies' latest entry also says "Other".
- FY2026Lapse of the Ninth Series of Stock Acquisition Rights and addition of a subsidiary schemeAnnual report
「Before vesting Lapsed 3,400,000」
The 3,400,000 shares covered by the Ninth Series stock acquisition rights, subject to consolidated operating profit exceeding ¥30 billion, lapsed before vesting. Meanwhile, at a subsidiary, 74,770 shares under the Third Series stock acquisition rights, subject to operating profit exceeding ¥800 million in February 2026, were granted in addition to the First and Second Series, which were subject to revenue exceeding ¥1.7 billion. - FY2023-Q3ReframedAnnual report
「Takao Hatori (羽鳥 貴夫), the Company's representative director and president, established a trust for stock acquisition rights issued at market value on 28 October 2022, with コタエル信託株式会社 as trustee, pursuant to a resolution of the Board of Directors dated 21 October 2022, for the purpose of providing incentives to increase corporate value over the medium to long term and retaining outstanding talent among the current and future directors, audit & supervisory board members and employees of the Company's group (collectively, “officers and employees”). On 7 November 2022, the Company issued the Ninth Series stock acquisition rights to this trust, pursuant to the Companies Act.」
After the previous stock acquisition rights lapsed, 34,000 Ninth Series stock acquisition rights, covering 3.4 million underlying shares, were newly issued. The structure was redesigned so that the number distributed would be determined based on evaluations of future contributions and future hires could also be eligible. - FY2021DroppedAnnual report
「The Fifth Series stock acquisition rights resolved at the Board of Directors meeting held on 13 October 2016 (number of rights: 21,000) and the Eighth Series stock acquisition rights resolved at the Board of Directors meeting held on 12 July 2017 (number of rights: 12,000)」
The Fifth and Eighth Series stock acquisition rights lapsed on 28 February 2021 because the exercise conditions were not met. It was disclosed that the remaining stock acquisition rights under the performance-based incentive plan had ceased to exist. - FY2018Lapse of the Sixth Series stock acquisition rightsAnnual report
「2017 Sixth Series stock acquisition rights Common shares － 300 300 － － 2017 Seventh Series stock acquisition rights Common shares － 500 － 500 0 2017 Eighth Series stock acquisition rights Common shares － 1,200 － 1,200 1」
While the Sixth Series stock acquisition rights covering 300 thousand shares lapsed, the Seventh and Eighth Series were disclosed as balances covering 500 thousand and 1,200 thousand shares, respectively, before the start of their exercise periods. - FY2018-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
The Company issued 3,000 Sixth Series, 5,000 Seventh Series and 12,000 Eighth Series stock acquisition rights. The total number of underlying shares was 2 million, and the exercise price was ¥767 per share. The Sixth, Seventh and Eighth Series were linked, respectively, to operating profit conditions for the fiscal years ending February 2018, February 2019 and February 2021. - FY2018-Q1AdvancedAnnual report
「The Company will implement an incentive plan using a trust for stock acquisition rights issued at market value, with the aim of maintaining and enhancing the motivation of its officers and employees and providing incentives to increase corporate value over the medium to long term.」
The Company resolved to issue 3,000 Sixth Series, 5,000 Seventh Series and 12,000 Eighth Series stock acquisition rights. Eligibility was expanded from the Company's directors and employees to include directors and employees of subsidiaries and affiliates, with the rights linked to operating profit targets for the fiscal years ending February 2018, February 2019 and February 2021. - FY2017RestatedAnnual report
「The stock acquisition rights issued during the current fiscal year are as follows.」
The annual report disclosed the issuance of 9,000 Fourth Series stock acquisition rights, 21,000 Fifth Series stock acquisition rights and a total of 3 million underlying shares. - FY2017-Q3AdvancedAnnual report
「The share acquisition rights issued during the three-month period ended in the third quarter are as follows.」
The issuance of 9,000 Fourth Series and 21,000 Fifth Series stock acquisition rights was disclosed. The exercise conditions for the Fourth Series and Fifth Series were operating profit for the fiscal years ending February 2018 and February 2021, respectively, and the exercise periods began on 1 June 2018 and 1 June 2021, respectively. - FY2017-Q2First statedAnnual report
「To maintain and enhance the motivation of its officers and employees and provide incentives to increase corporate value over the medium to long term, the Company will implement this incentive plan under a trust agreement for stock acquisition rights issued at market value, with its honorary chairman, Kiji Hatori (羽鳥 兼市), as settlor and Mutsumi Hagiwara (萩原 睦美) as trustee.」
The Company established “IDOM2018,” comprising 9,000 Fourth Series stock acquisition rights, and “IDOM2021,” comprising 21,000 Fifth Series stock acquisition rights. Contributions to consolidated performance during the personnel evaluation period and achievements in planning and promotion, new business development and management will be evaluated, and the number of rights to be distributed to officers and employees will be determined upon expiration of the trust period. The number distributed to executive-level personnel will be determined within a range of 0% to 120% of the incentive package.